Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
CVS HEALTH Corp
CVS Health announced the resignation of director Larry Robbins effective August 13, 2026, and the appointment of Teresa Heitsenrether to the Board of Directors effective November 18, 2026. Heitsenrether, currently the Chief Data & Analytics Officer at JPMorgan Chase, will support the company's strategic transition into a data-driven health technology firm.…more
CVS HEALTH Corp
CVS Health Corp가 2026년 6월 30일 기준 기관 투자자의 보유 현황을 담은 13F-HR 보고서를 2026년 8월 6일에 제출했습니다. 본 공시는 기관 투자자들의 분기별 주식 보유 내역을 공개하는 정기 보고서로, 회사의 재무 실적이나 경영상의 직접적인 변경 사항을 포함하지 않습니다.…more
CVS HEALTH Corp
CVS Health Corporation은 2026년 5월 22일자로 기존 신용 계약에 대한 제3, 제4, 제5차 수정안을 체결하여 차입 조건을 변경했습니다. 이번 공시는 회사의 재무적 유연성을 확보하기 위한 신용 한도 및 계약 조건의 갱신을 포함하고 있으며, 임직원을 대상으로 한 제한조건부주식(RSU) 보상 계약의 세부 사항도 함께 명시되었습니다.…more
3 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
CVS Agrees to $315 Million Settlement Over Illegal Opioid Prescriptions…more
CVS Health has agreed to pay $315 million to resolve allegations of illegally dispensing opioids and submitting invalid claims to government healthcare programs. While this settlement resolves past legal issues, the company must now adhere to strict compliance monitoring under a new agreement.…more
●●●●●●●● ●●●●● ●●●●●●
UnitedHealth Group expects its Medicaid business margins to reach a trough in 2026 before recovering to target levels by 2028. The company is also focusing on network optimization and favorable Medicare Advantage ratings to manage rising medical costs.…more
●●●●●●●● ●●●●● ●●●●●●
CVS has agreed to pay $315 million to resolve allegations of illegally filling unlawful opioid prescriptions and submitting false claims to the federal government. While the settlement resolves legal exposure, it represents a significant financial penalty for the company.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.